Literature DB >> 7527581

Functional CD40 on B lymphocytes and dendritic cells.

C Caux1, N Burdin, L Galibert, P Hermann, N Renard, C Servet-Delprat, J Banchereau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7527581     DOI： 10.1016/s0923-2494(94)80190-8

Source DB:  PubMed          Journal:  Res Immunol        ISSN： 0923-2494


× No keyword cloud information.
  10 in total

Review 1.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

2.  Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge.

Authors:  Nikolay Korokhov; Galina Mikheeva; Alexander Krendelshchikov; Natalya Belousova; Vera Simonenko; Valentina Krendelshchikova; Alexander Pereboev; Alexander Kotov; Olga Kotova; Pierre L Triozzi; Wayne A Aldrich; Joanne T Douglas; Kin-Ming Lo; Papia T Banerjee; Stephen D Gillies; David T Curiel; Victor Krasnykh
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

3.  Morphological interactions of interdigitating dendritic cells with B and T cells in human mesenteric lymph nodes.

Authors:  K Takahashi; A Kenji; T Norihiro; K Eisaku; O Takashi; H Kazuhiko; Y Tadashi; A Tadaatsu
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV.

Authors:  Rongxin Zhang; Sheng Zhang; Min Li; Changyi Chen; Qizhi Yao
Journal:  Vaccine       Date:  2010-05-14       Impact factor: 3.641

5.  Macrophage effector responses of horses are influenced by expression of CD154.

Authors:  Brett A Sponseller; Sandra K Clark; Jessica Gilbertie; David M Wong; Kate Hepworth; Sarah Wiechert; Prashanth Chandramani; Beatrice T Sponseller; Cody J Alcott; Bryan Bellaire; Andrew C Petersen; Douglas E Jones
Journal:  Vet Immunol Immunopathol       Date:  2016-08-26       Impact factor: 2.046

6.  CD154 is a negative regulator of autoaggressive CD8+ T cells in type 1 diabetes.

Authors:  Catrin M McGregor; Stephen P Schoenberger; E Allison Green
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-10       Impact factor: 11.205

Review 7.  Targeted drug delivery in pancreatic cancer.

Authors:  Xianjun Yu; Yuqing Zhang; Changyi Chen; Qizhi Yao; Min Li
Journal:  Biochim Biophys Acta       Date:  2009-10-22

8.  The dinucleotide repeat polymorphism in the 3'UTR of the CD154 gene has a functional role on protein expression and is associated with systemic lupus erythematosus.

Authors:  M J Citores; I Rua-Figueroa; C Rodriguez-Gallego; A Durántez; M I García-Laorden; C Rodríguez-Lozano; J C Rodríguez-Pérez; J A Vargas; P Pérez-Aciego
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

9.  CD28 and inducible costimulator (ICOS) signalling can sustain CD154 expression on activated T cells.

Authors:  Denise A Kaminski; Byung O Lee; Sheri M Eaton; Laura Haynes; Troy D Randall
Journal:  Immunology       Date:  2008-12-13       Impact factor: 7.397

10.  Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion.

Authors:  Irina Y Tcherepanova; Melissa D Adams; Xiaorong Feng; Atsushi Hinohara; Joe Horvatinovich; David Calderhead; Don Healey; Charles A Nicolette
Journal:  BMC Mol Biol       Date:  2008-10-17       Impact factor: 2.946
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.